1. The mechanisms of central angiotensin I1 blood pressure effects in conscious dogs on normal or sodium-deficient diets were examined.
Introduction
When angiotensin I1 (ANG 11) is injected into the brain ventricles it produces an increase of arterial blood pressure, release of pituitary hormones, stimulates drinking behaviour and interferes with memory processes (Severs & Daniels-Severs, 1973; Morgan & Routtenberg, 1977; Brosnihan, Berti & Ferrario, 1979; Koller, Krause, Hoffmeister & Ganten, 1979; Simonnet, Rodriguez, Fumoux, Czernichow & Vincent, 1979) . Evidence that ANG I1 can be generated within the brain in connection with a brain renin-angiotensin system has been presented (Ganten & Speck, 1978) . The biosynthesis of endogenous brain ANG I1 from its local precursor angiotensinogen can be induced in vivo by injection of renin into the brain ventricles. Owing to the high concentrations of angiotensinogen in cerebrospinal fluid (CSF) (Printz & Lewicki, 1977 ) ANG I can be generated from angiotensinogen, if renin is injected intracerebroventricularly. Brain converting enzyme will then convert ANG I into ANG 11, which stimulates specific brain ANG I1 receptors, inducing an increase of arterial blood pressure (Ganten & Speck, 1978) .
The present experiments in conscious dogs were carried out to evaluate the mechanisms of blood pressure changes induced by locally formed brain ANG I1 and to assess whether sodium restriction could influence the mechanisms of central ANG I1 blood pressure effects.
Methods
Adult male beagles between 14.5 and 19.0 kg with a chronically implanted cannula in the third brain ventricle (n = 5) were kept on a normal control diet (70 mmol of sodium, 205 mmol of potassium/day). Sodium restriction was produced in the same dogs 8-12 weeks later by a low salt diet (C 4036, Altromin GmbH, 4937 Lage, F.R. Germany), which provides 6 mmol of sodium daily and by administration of frusemide (10 mg/kg orally) for 7 days. Tap water was available ad libitum. The dogs were kept in individual metabolic cages during sodium depletion.
All drugs were dissolved in 0. Blood was taken from a brachial vein at 20 min before and at 15, 60 and 300 min after intracerebroventricular injections. Plasma renin concentration, A N G 11, corticosterone and A D H were determined by radioimmunoassay (Mann, Johnson & Ganten, 1980) . Noradrenaline and adrenaline in plasma were measured by a radioenzymatic method (Da Prada & Ziircher, 1976) .
In separate experiments the volume of water drunk 6 0 min after the intracerebroventricular injections was recorded.
The dogs were all adapted to the experimental procedure and all experiments were performed in conscious unrestrained dogs.
Values are given as means & SEM. Results were analysed by Student's paired and unpaired t-test if appropriate. The 5% probability level was used as the criterion of significance.
Results
Intracerebroventricular injections of renin in a dose of 0.5 unit induced an increase of arterial blood pressure ( P < 0.001) in dogs on a normal and on a low sodium diet. Sodium restriction had no significant effect on the magnitude of the renin-induced pressor response.
Drinking was stimulated in all dogs on both regimens 3-15 min after renin injections into the third brain ventricle (P < 0.001). Between 350 and 1600 ml of water was drunk within 1 h after from 227 k 37 to 102 26 fmol/ml ( P < 0.01).
Intracerebroventricular injection of the A N G I1
antagonist saralasin alone caused the opposite effect: an increase of plasma renin ( P < 0.01) and of A N G I1 concentrations (P < 0.05); the same changes were also seen after simultaneous injection of captopril in combination with renin.
Intracerebroventricular administration of renin increased ADH, noradrenaline, adrenaline and corticosterone in dogs on both dietary regimens. In dogs on a normal diet A D H increased threefold (P < 0.05), noradrenaline by 58% ( P < 0.02), adrenaline by 81% ( P < 0.05) and corticosterone by 86%. In dogs on a low sodium diet A D H increased by 159% from 3.6 k 0.4 to 9.4 3.4 pg/ml, noradrenaline by 76% from 0.21 0.05 to 0.37 +_ 0.07 ng/ml, adrenaline by 27% from 0.24 k 0.06 to 0.30 & 0.03 ng/ml and corticosterone by 157% from 0.7 k 0.1 to 1.8 k 0.1 pg/lOO ml ( P < 0.001). These central renin Brain angiotensin and blood pressure regulation 55s effects were inhibited by simultaneous intracerebroventricular injections of captopril. Intracerebroventricular saralasin alone was without significant effect on plasma catecholamines, ADH or corticosterone.
Discussion
Intracerebroventricular administration of renin leads to the local formation of brain ANG 11, which in turn increases arterial blood pressure (Reid & Ramsay, 1975; Scholkens, Steinbach & Ganten, 1979; Schelling, Ganten, Sponer, Unger & Ganten, 1980) . The magnitude of this central pressor response to endogenously formed brain ANG I1 or to exogenously administered ANG I1 (Brosnihan et al., 1979) in dogs is not influenced by sodium restriction, whereas peripheral intravenous pressor responses to ANG I1 were attenuated by sodium depletion (Liang, Gavras & Hood, 1978) , suggesting different mechanisms in the brain and periphery. In all dogs on both regimens copious drinking was induced by intracerebroventricular renin (Reid & Ramsay, 1975) . This drinking behaviour in response to central ANG I1 during various states of sodium balance was also seen in rats (Kapsha, Keil, Klase & Severs, 1979) . The ANG converting enzyme inhibitor captopril completely inhibited the centrally evoked drinking responses in dogs and the pressor responses in rats (Scholkens, 1979) . Plasma renin and plasma ANG I1 concentrations decreased in all dogs. However, the suppression was more prominent after sodium restriction with an activated plasma renin-angiotensin system. This is in agreement with results in rats maintained on a low sodium intake where plasma renin activity was suppressed after intracerebroventricular injection of ANG I1 (Kapsha et al., 1979) . In contrast, intracerebroventricular injection of saralasin caused the opposite effect: an increase of plasma renin and ANG 11. Thus there appears to be a coupling between the brain renin-angiotensin system and the circulating plasma rcnin-angiotensin system (Reid & Day, 1977; Ganten & Stock, 1978; Kapsha et al., 1979) , which may be mediated by blood pressure changes or by humoral and/or neural pathways (Ganten & Speck, 1978) . Stimulation of brain ANG I1 biosynthesis increased plasma ADH in conscious dogs as it was seen with intracerebroventricular injections of ANG I1 in monkeys (Simonnet et al., 1979 ) and rats (Haack & Mohring, 1978) . Apart from its volume-retaining effect, ADH has been proposed to be also a pressor hormone (Mohring, 1978) and to potentiate vascular effects of various vasoconstrictor agents (Karmazyn, Manku & Horrobin, 1978 
